An Interview with Innocan Pharma’s CEO, Iris Bincovich. Innocan Pharma is gaining attention for its innovative pain relief solutions — particularly through its slow-release injection technology. This cutting-edge approach delivers synthetic Cannabidi...
The past week has been eventful for the TSX , reflecting the broader economic and political landscape. Monday: Canada’s main stock index managed to maintain composure, registering a controlled loss following the unexpected resignation of Prime Minis...
Jonathon Brown
|
11 days ago
|
TSX this week The TSX has experienced a rocky week, marked by five consecutive sessions of declines. This downturn coincided with the unexpected resignation of Canada’s Finance Minister , Chrystia Freeland, just hours before she was scheduled to pre...
Jonathon Brown
|
December 19, 2024
|
Author: Lane Simond . The most common narrative about recycling electronics is that it is better for the environment, but business owners have even more reasons to make sure their outdated technology gets into the hands of a reputable recycler. Three reasons to...
Research
|
December 18, 2024
|
In the above video we have a conversation with Aleks Paunovic, co-owner of newly launched Legend Water , a company on a mission for profits and purpose. As well, to diversify your portfolio, check out three TSX water companies that are significantly up on the...
Coreena Robertson
|
December 16, 2024
|
As 2024 draws to a close, it is worth considering new investments for the future. A successful investment in the technology sector requires a sound strategy, thorough research, and an understanding of the ins and outs of the industry. We have summarized key points for in...
Mario Hose
|
December 16, 2024
|
By Brad Sorensen, CFA, Zacks Research. NurExone Biologic (TSXV:NRX; OTCQB:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting preclinical tests for other conditions that ExoPTEN m...
Research
|
December 11, 2024
|
Lode Gold (TSXV:LOD) has had a year of growth achieving one milestone after another. Despite facing a challenging market, the company has successfully raised $6M since March 2024. Now, investors have the chance to capitalize on a unique opportunity by investing in Lode ...
Research
|
December 4, 2024
|
This week, Canada’s main stock index, the TSX , hit another record high, supported by strong retail sales data and positive investor sentiment. However, the index quickly fell from grace following U.S. President-elect Donald Trump’s announ...
Jonathon Brown
|
November 28, 2024
|
The CO2 markets and emissions trading are among the few winners of the climate conference in Baku. The dynaCERT share should benefit, as the technology company could face a surge of orders in 2025, potentially leading to a revaluation of the stock. Siemens Energy has rece...
Fabian Lorenz
|
November 27, 2024
|